Zura Bio Limited

US$4.09As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ZURAHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (15.83%)
Div yield —
ROE (63.17%)
Biotechnology
Beta (5Y) 0.02
PE TTM —
TSR TTM 6.51%
Mkt cap US$394.0M
ROIC (43.06%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.46
9.12%
(31.50%)
Hold 3|6|8|11|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.07
0.07
0.08
8.25%
1.53%
5.51%
9.24%
Revenue$M
35.40
37.12
39.14
40.65
7.50%
11.87%
12.63%
12.85%
Peers (US$394.0M)
Cap (US$)
PE
393.9M
203.0x
Capital
TTM
5Y
10Y
Leveragex
0.251
(0.169)
(0.165)
EBIT/Intx
7.376
0.523
0.419
Own earn%
(104.44)
10.44
24.04
Sh yield%
39.70
38.78
38.94
Owners
Insiders/Inst%
1.16
45.14
Short interest%
5.88
SBC / revenue%
1.80
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
17–21
$1 testx
0.0
Incr. ROIC%
11